TARGETED EPIGENETIC REACTIVATION OF DORMANT TUMOR SUPPRESSORS: NEW PRECISION THERAPIES FOR LIVER CANCER. [ 2019 - ]

Research Grant

Brief description Liver cancer has the second highest mortality rate of all cancers, its incidence in Australia is increasing, and current treatment options are very limited. A recent, large study of liver cancer has highlighted several protective 'tumour suppressor genes' that are found dormant in liver cancer patients. We are developing tailored therapies to simultaneously restore the activity of these genes to control the spread and relapse of these cancers, while rendering them more sensitive to chemotherapy.

Funding Amount $1,139,460.00

Funding Scheme Project Grants

Notes Standard Project Grant